Cruxi AI

What is Cruxi AI?

Cruxi AI is an AI-powered regulatory intelligence and document drafting platform built for medical device manufacturers, regulatory affairs consultants, and medtech startups. Cruxi AI integrates FDA regulations, guidance documents, product codes, MAUDE adverse events, recalls, and historical 510(k) clearance data to automate device classification, predicate finding, evidence planning, and eSTAR submission drafting. Featuring both full-submission agentic workflows and a hotkey-activated Universal Toolbar, Cruxi AI helps regulatory professionals compile compliant, fully cited submission packages with minimal manual overhead.

Cruxi AI reduces medical device regulatory research and submission preparation timelines by up to 60 percent. The platform indexes hundreds of thousands of FDA regulatory records, standards, and historical 510(k) summaries to provide cited, traceable answers in seconds. Medtech startups and regulatory consultants using Cruxi AI reduce the risk of Refuse to Accept (RTA) administrative holds by over 40 percent through automated compliance checking. Its context-aware drafting tools enable teams to produce grounded, audit-ready regulatory dossiers up to 4 times faster than manual drafting methods.

• Founder: Ben Carter
• Launch Year: 2025
• Use Cases:
  • FDA 510(k), De Novo, and eSTAR regulatory submission drafting
  • Medical device classification and regulatory pathway determination
  • Predicate device identification, comparison, and substantial equivalence analysis
  • MAUDE database post-market surveillance and adverse event research
• Technology:
  • Vertical Large Language Models fine-tuned on regulatory data
  • Retrieval-Augmented Generation (RAG) with grounded source citations
  • FDA database sync (510k clearances, product codes, MAUDE, recalls)
• Target Users:
  • Regulatory affairs managers, directors, and specialists
  • Medical device startups and biotech entrepreneurs
  • Independent regulatory and clinical compliance consultants
  • Quality assurance and medtech research engineers
• Acquisition: Operates as an independent vertical AI technology company

Key features of Cruxi AI

Cruxi AI's key features are

• AI-Driven Device Classification: Automatically analyzes device technical descriptions and intended use to determine exact FDA product codes, regulation numbers, and device classes.
• Intelligent Predicate Finder & Comparison: Scours historical 510(k) clearances to identify and generate structured comparison tables against primary and secondary predicate devices.
• Grounded eSTAR Section Drafting: Drafts standardized regulatory submission sections with automatic inline citations linked directly to uploaded test reports and FDA guidance.
• Automated RTA & Compliance Checks: Evaluates draft submission dossiers against official FDA Refuse to Accept (RTA) criteria to catch missing data prior to filing.
• Regulatory Intelligence & MAUDE Analysis: Queries adverse events, recalls, and post-market safety records to identify potential safety risks and predicate vulnerabilities.
• Universal Desktop Toolbar: Hotkey-activated Windows toolbar that allows users to query, summarize, and draft from their uploaded workspace directly within any desktop app.
• Private Secure Knowledge Base: Connects internal test reports, device design history files (DHFs), and clinical evidence in an isolated, encrypted workspace.
• Modular Micro-Services: Offers flexible standalone modules for focused tasks such as classification, predicate analysis, or individual section generation.

Cruxi AI Pricing

Cruxi AI operates on a flexible credit-based and tiered subscription model designed for both early-stage medtech startups and high-volume regulatory consulting firms.

Free / Community Tier:

• $0/month
• Initial trial credits to test device classification and search predicates
• Basic workspace drafting access

Starter / Startup Plan:

• Credit-based or monthly subscription model
• Designed for early-stage device teams preparing a single 510(k) or eSTAR submission
• Includes full predicate comparison and RTA compliance checking

Professional / Consultant Tier:

• Tiered pricing for regulatory consultancies
• Multi-project management, higher citation parsing limits, and priority database syncing

Enterprise Custom Tier:

• Custom enterprise agreements
• Dedicated private infrastructure, custom workflow connectors, and dedicated regulatory support

Disclaimer: For the latest and most accurate pricing information, please visit the official Cruxi AI website.

Who is using Cruxi AI?

Cruxi AI is designed for a broad range of medical device and regulatory professionals, including

• Medical Device Startups: Accelerating their first FDA 510(k) or De Novo submission to reach market quickly
• In-House RA Directors: Ensuring submission accuracy, standardizing dossiers, and maintaining audit trails
• Regulatory Consultants: Handling multiple client device submissions simultaneously with less manual overhead
• QA & Clinical Engineers: Mapping out technical standards, biocompatibility protocols, and evidence requirements
• Content & Compliance Specialists: Using writing tools to compile clear technical documentation and summary reports
• Medtech Investors: Evaluating device regulatory feasibility and predicate risk during technical due diligence

Best Cruxi AI Alternatives

Some of the strongest Cruxi AI alternatives include

• Emergo by UL (RAMS)
• Labrynth AI
• Greenlight Guru
• MasterControl
• Qualio
• Box Extract

Pros and Cons of Cruxi AI

Pros

• Built specifically for medical device regulatory workflows with native FDA database integration
• Generates grounded, fully cited drafts linked directly to underlying evidence documents
• Universal Toolbar enables quick context-aware drafting across any desktop application
• Automates time-consuming predicate searches and device classification in minutes
• Modular architecture supports both end-to-end submissions and quick micro-tasks

Cons

• Primarily focused on US FDA pathways, with international regulatory frameworks continually expanding
• Regulatory outputs still require thorough human review and sign-off by qualified RA experts
• Advanced submission features and large file batches require paid tier scaling
• Desktop universal toolbar is currently optimized primarily for Windows environments

Why Choose Cruxi AI?

Cruxi AI is the premier choice for medical device companies and regulatory consultants who want to eliminate manual regulatory research and accelerate FDA clearance timelines.

• Replaces days of manual FDA database searching with instant, cited regulatory intelligence
• Minimizes the risk of costly FDA rejection letters and additional information requests
• Generates grounded submission sections directly from your private technical evidence files
• Integrates seamlessly into daily workflows via the hotkey-activated Universal Toolbar
• Provides flexible modular workflows tailored for both solo founders and enterprise RA teams

Cruxi AI vs. Competitors

The main difference between Cruxi AI, Emergo RAMS, Greenlight Guru, and Box Extract is that Cruxi AI provides agentic vertical AI specifically engineered to automate FDA 510(k) and eSTAR drafting using real-time regulatory databases, while Emergo RAMS focuses on global registration tracking, Greenlight Guru specializes in quality management systems (eQMS), and Box Extract focuses on generalized enterprise metadata extraction. Cruxi AI stands out for its specialized regulatory reasoning, predicate finding, and grounded document synthesis.

How do we rate Cruxi AI?

Cruxi AI Review

Cruxi is a specialized AI platform designed for medical device regulatory workflows, and its performance reflects that niche focus. It excels at automating complex tasks like device classification, predicate analysis, and submission drafting, which can save teams significant time and effort. Many users highlight its ability to deliver detailed regulatory insights quickly, calling it “revolutionary” for FDA-related work. However, feedback is somewhat mixed—while several users praise its efficiency, others report issues with communication and consistency in results. Overall, Cruxi is a powerful tool for regulatory teams, but it works best when paired with human review and expertise.

Conclusion

Cruxi is a powerful and focused solution for medical device companies navigating complex regulatory processes. By automating tasks like classification, documentation, and submission planning, it significantly reduces manual effort and speeds up time-to-market. Its AI-driven approach brings efficiency and structure to workflows that are traditionally time-consuming and detail-heavy. While it may still require human oversight to ensure accuracy and compliance, its value in improving productivity is clear. Overall, Cruxi stands out as a modern tool that helps regulatory teams work smarter, stay compliant, and manage submissions more effectively in an increasingly demanding healthcare environment.